MicroRNA-34a (miR-34a) is expressed in the myocardium and expression is altered after myocardial injury. We investigated the effects of miR-34a on heart function after ischemia–reperfusion (IR) injury. Cardiomyocytes were isolated from neonatal rat hearts and simulated IR injury was induced in vitro. Following IR injury in rats, infarct size was measured and left ventricular (LV) function was evaluated using echocardiography. Protein expression of silent information regulator 1 (SIRT1), acetylated p53 (ac-p53), Bcl-2 and Bax, and miR-34a and SIRT1 gene levels were analyzed. miR-34a overexpression exacerbated myocardial injury by increasing apoptosis and infarct size and decreasing LV function. Suppression of miR-34a attenuated myocardial IR injury. SIRT1 was negatively regulated by miR-34a and the expression of downstream genes, such as ac-p53, Bcl-2, and Bax were altered correspondingly. Increased expression of miR-34a aggravates injury after IR; miR-34a suppression therapy may represent a new line of treatment for myocardial IR injury.
Get full access to this article
View all access options for this article.
References
1.
MackmanN. (2008). Triggers, targets and treatments for thrombosis. Nature, 451:914–918.
2.
CokkinosDV and PantosC. (2007). Myocardial protection in man—from research concept to clinical practice. Heart Fail Rev, 12:345.
3.
WuHH, HsiaoTY, ChienCT and LaiMK. (2009). Ischemic conditioning by short periods of reperfusion attenuates renal ischemia/reperfusion induced apoptosis and autophagy in the rat. J Biomed Sci, 16:1–10.
4.
KoshinumaS, MiyamaeM, KanedaK, KotaniJ and FigueredoVM. (2014). Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury. J Anesth, 28:235–241.
BernardoBC, CharcharFJ, LinRCY and McMullenJR. (2012). A microRNA guide for clinicians and basic scientists: background and experimental techniques. Heart Lung Circ, 21:131–142.
7.
HuangZP, ChenJ, SeokHY, ZhangZ, KataokaM and HuX. (2013). MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res, 112:1234.
8.
ChenJJ and ZhouSH. (2011). Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. Cardiol J, 18:675–681.
9.
BoonRA, IekushiK, LechnerS, SeegerT, FischerA, HeydtS, KaluzaD, TréguerK, CarmonaG, et al. (2013). MicroRNA-34a regulates cardiac ageing and function. Nature, 495:107–110.
10.
TabuchiT, SatohM, ItohT and NakamuraM. (2012). MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. Clin Sci (Lond), 123:161–171.
11.
SadoshimaJ, JahnL, TakahashiT, KulikTJ and IzumoS. (1992). Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem, 267:10551–10560.
12.
BecattiM, TaddeiN, CecchiC, NassiN, NassiPA and FiorilloC. (2012). SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes. Cell Mol Life Sci, 69:2245–2260.
13.
ZengC, KeZ, SongY, YaoY, HuX and ZhangM. (2013). Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance. Exp Mol Pathol, 95:23–31.
14.
WangY, LiuJ, MaA and ChenY. (2015). Cardioprotective effect of berberine against myocardial ischemia/reperfusion injury via attenuating mitochondrial dysfunction and apoptosis. Int J Clin Exp Med, 8:14513–14519.
15.
ChenK, LiG, GengF, ZhangZ, LiJ and YangM. (2014). Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats. Apoptosis, 19:946–957.
16.
SkommerJ, RanaI, MarquesFZ, ZhuW, DuZ and CharcharFJ. (2014). Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death. Cell Death Dis, 5:e1325.
17.
LeiW, HeH, YangF, KongB, HeH and KeH. (2014). Effects of downregulation of microRNA-181a on h2o2-induced h9c2 cell apoptosis via the mitochondrial apoptotic pathway. Oxid Med Cell Longev, 2014:960362.
18.
LinCC, ChangYM, PanCT, ChenCC, LingL and TsaoKC. (2014). Functional evolution of cardiac microRNAs in heart development and functions. Mol Biol Evol, 31:2722–2734.
19.
HuangY, QiY, DuJQ and ZhangDF. (2014). MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting smad4. Expert Opin Ther Targets, 18:1355–1365.
20.
YuanHY, ZhouCB, ChenJM, LiuXB, WenSS, XuG and ZhuangJ. (2017). MiR-34a targets regulator of calcineurin 1 to modulate endothelial inflammation after fetal cardiac bypass in goat placenta. Placenta, 51:49–56.
21.
BernardoBC and McmullenJR. (2012). Therapeutic inhibition of the mir-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci U S A, 109:17615–17620.
22.
NadtochiySM, YaoH, McBurneyMW, GuW, GuarenteL, RahmanI and BrookesPS. (2011). SIRT1-mediated acute cardioprotection. Am J Physiol Heart Circ Physiol, 301:H1506–H1512.
23.
LiuX, ChenH, ZhuW, ChenH, HuX and JiangZ. (2014). Transplantation of SIRT1-engineered aged mesenchymal stem cells improves cardiac function in a rat myocardial infarction model. J Heart Lung Transplant, 33:1083–1092.
24.
HsuCP, ZhaiP, YamamotoT, MaejimaY, MatsushimaS and HariharanN. (2010). Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation, 122:2170–2182.
25.
TannoM, KunoA, HorioY and MiuraT. (2012). Emerging beneficial roles of sirtuins in heart failure. Basic Res Cardiol, 107:273.
26.
VogelsteinB, LaneD and LevineAJ. (2000). Surfing the p53 network. Nature, 408:307–310.
27.
VogelsteinB and KinzlerKW. (2004). Cancer genes and the pathways they control. Nat Med, 10:789–799.
28.
Nural-GuvenerHF, ZakharovaL, NimlosJ, PopovicS, MastroeniD and GaballaMA. (2014). HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation. Fibrogenesis Tissue Repair, 7:10.
29.
YamamotoT and SadoshimaJ. (2011). Protection of the heart against ischemia/reperfusion by silent information regulator 1. Trends Cardiovasc Med, 21:27–32.
30.
FanY, LiuK, WangQ, RuanY, ZhangY and YeW. (2014). Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis. Mol Vis, 20:1557–1568.
31.
MelkoumianZ, WeberJL, WeberDM, FadeevAG, ZhouY and Dolley-SonnevilleP. (2010). Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol, 28:606–610.
32.
MummeryC, Ward-van OostwaardD, DoevendansP, SpijkerR, van den BrinkS, HassinkR and PassierR. (2003). Differentiation of human embryonic stem cells to cardiomyocytes. Circulation, 107:2733–2740.
33.
ChunYW, BalikovDA, FeasterTK, WilliamsCH, ShengCC and LeeJB. (2015). Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes. Biomaterials, 67:52–64.
34.
GonzalezR, LeeJW and SchultzPG. (2011). Stepwise chemically induced cardiomyocyte specification of human embryonic stem cells. Angew Chem Int Ed Engl, 123:11181–11185.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
